Sickle Cell Transplant Advocacy & Research Alliance (STAR) Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2019
NCT03924401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sickle Cell Transplant Advocacy & Research Alliance (STAR)